Zoetis Inc. (NYSE:ZTS) Shares Bought by 180 Wealth Advisors LLC

180 Wealth Advisors LLC increased its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 22.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,716 shares of the company’s stock after purchasing an additional 674 shares during the period. 180 Wealth Advisors LLC’s holdings in Zoetis were worth $606,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in the stock. Darwin Wealth Management LLC purchased a new stake in shares of Zoetis in the third quarter worth about $31,000. First Personal Financial Services purchased a new position in Zoetis in the 3rd quarter worth approximately $33,000. Capital Performance Advisors LLP purchased a new position in Zoetis in the 3rd quarter worth approximately $33,000. Dunhill Financial LLC grew its position in Zoetis by 80.6% in the third quarter. Dunhill Financial LLC now owns 168 shares of the company’s stock valued at $33,000 after acquiring an additional 75 shares in the last quarter. Finally, Quarry LP raised its stake in shares of Zoetis by 273.2% during the second quarter. Quarry LP now owns 209 shares of the company’s stock valued at $36,000 after purchasing an additional 153 shares during the period. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on ZTS shares. Leerink Partnrs raised shares of Zoetis to a “strong-buy” rating in a report on Monday, December 2nd. UBS Group began coverage on Zoetis in a research report on Monday, December 9th. They set a “neutral” rating and a $196.00 target price on the stock. Leerink Partners initiated coverage on Zoetis in a report on Monday, December 2nd. They issued an “outperform” rating and a $215.00 price target for the company. JPMorgan Chase & Co. lifted their price objective on Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Finally, Stifel Nicolaus reduced their target price on Zoetis from $210.00 to $180.00 and set a “buy” rating for the company in a research note on Tuesday, January 7th. One equities research analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of $211.89.

Zoetis Trading Down 1.2 %

NYSE ZTS opened at $164.31 on Wednesday. The firm has a market capitalization of $74.13 billion, a PE ratio of 30.89, a price-to-earnings-growth ratio of 2.91 and a beta of 0.89. Zoetis Inc. has a one year low of $144.80 and a one year high of $200.53. The company has a 50-day simple moving average of $171.31 and a 200-day simple moving average of $180.16. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.27 and a current ratio of 3.69.

Zoetis (NYSE:ZTS) last issued its earnings results on Monday, November 4th. The company reported $1.58 EPS for the quarter, beating analysts’ consensus estimates of $1.46 by $0.12. The company had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.29 billion. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. Zoetis’s quarterly revenue was up 11.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.36 earnings per share. On average, equities analysts forecast that Zoetis Inc. will post 5.9 earnings per share for the current year.

Zoetis Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 4th. Stockholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 1.22%. This is a positive change from Zoetis’s previous quarterly dividend of $0.43. Zoetis’s dividend payout ratio is currently 37.59%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.